11-1257566-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_002458.3(MUC5B):​c.16306G>A​(p.Val5436Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0291 in 1,607,968 control chromosomes in the GnomAD database, including 884 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.023 ( 57 hom., cov: 32)
Exomes 𝑓: 0.030 ( 827 hom. )

Consequence

MUC5B
NM_002458.3 missense

Scores

17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.00300

Publications

10 publications found
Variant links:
Genes affected
MUC5B (HGNC:7516): (mucin 5B, oligomeric mucus/gel-forming) This gene encodes a member of the mucin family of proteins, which are highly glycosylated macromolecular components of mucus secretions. This family member is the major gel-forming mucin in mucus. It is a major contributor to the lubricating and viscoelastic properties of whole saliva, normal lung mucus and cervical mucus. This gene has been found to be up-regulated in some human diseases, including sinus mucosa of chronic rhinosinusitis (CRS), CRS with nasal polyposis, chronic obstructive pulmonary disease (COPD) and H. pylori-associated gastric disease, and it may be involved in the pathogenesis of these diseases. [provided by RefSeq, Jul 2010]
MUC5B Gene-Disease associations (from GenCC):
  • interstitial lung disease
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0031365752).
BP6
Variant 11-1257566-G-A is Benign according to our data. Variant chr11-1257566-G-A is described in ClinVar as Benign. ClinVar VariationId is 164009.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0228 (3479/152290) while in subpopulation NFE AF = 0.0328 (2228/68016). AF 95% confidence interval is 0.0316. There are 57 homozygotes in GnomAd4. There are 1737 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 57 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MUC5BNM_002458.3 linkc.16306G>A p.Val5436Met missense_variant Exon 41 of 49 ENST00000529681.5 NP_002449.2 Q9HC84

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MUC5BENST00000529681.5 linkc.16306G>A p.Val5436Met missense_variant Exon 41 of 49 5 NM_002458.3 ENSP00000436812.1 Q9HC84
MUC5BENST00000526859.1 linkc.-60G>A upstream_gene_variant 3 ENSP00000434539.1 H0YDX8

Frequencies

GnomAD3 genomes
AF:
0.0229
AC:
3479
AN:
152172
Hom.:
57
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00557
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.00687
Gnomad ASJ
AF:
0.0285
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00809
Gnomad FIN
AF:
0.0690
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0328
Gnomad OTH
AF:
0.0201
GnomAD2 exomes
AF:
0.0254
AC:
6197
AN:
243876
AF XY:
0.0254
show subpopulations
Gnomad AFR exome
AF:
0.00634
Gnomad AMR exome
AF:
0.00485
Gnomad ASJ exome
AF:
0.0283
Gnomad EAS exome
AF:
0.0000557
Gnomad FIN exome
AF:
0.0740
Gnomad NFE exome
AF:
0.0345
Gnomad OTH exome
AF:
0.0271
GnomAD4 exome
AF:
0.0298
AC:
43348
AN:
1455678
Hom.:
827
Cov.:
33
AF XY:
0.0292
AC XY:
21121
AN XY:
724348
show subpopulations
African (AFR)
AF:
0.00391
AC:
131
AN:
33474
American (AMR)
AF:
0.00521
AC:
233
AN:
44708
Ashkenazi Jewish (ASJ)
AF:
0.0292
AC:
762
AN:
26122
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39690
South Asian (SAS)
AF:
0.00952
AC:
821
AN:
86246
European-Finnish (FIN)
AF:
0.0718
AC:
3427
AN:
47706
Middle Eastern (MID)
AF:
0.00451
AC:
26
AN:
5766
European-Non Finnish (NFE)
AF:
0.0327
AC:
36319
AN:
1111670
Other (OTH)
AF:
0.0270
AC:
1628
AN:
60296
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
2524
5047
7571
10094
12618
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1330
2660
3990
5320
6650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0228
AC:
3479
AN:
152290
Hom.:
57
Cov.:
32
AF XY:
0.0233
AC XY:
1737
AN XY:
74454
show subpopulations
African (AFR)
AF:
0.00556
AC:
231
AN:
41566
American (AMR)
AF:
0.00686
AC:
105
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.0285
AC:
99
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5174
South Asian (SAS)
AF:
0.00809
AC:
39
AN:
4818
European-Finnish (FIN)
AF:
0.0690
AC:
733
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0328
AC:
2228
AN:
68016
Other (OTH)
AF:
0.0199
AC:
42
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
181
361
542
722
903
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0288
Hom.:
199
Bravo
AF:
0.0172
TwinsUK
AF:
0.0302
AC:
112
ALSPAC
AF:
0.0330
AC:
127
ESP6500AA
AF:
0.00746
AC:
32
ESP6500EA
AF:
0.0317
AC:
269
ExAC
AF:
0.0270
AC:
3256
Asia WGS
AF:
0.00375
AC:
13
AN:
3478
EpiCase
AF:
0.0252
EpiControl
AF:
0.0264

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Feb 21, 2013
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Val5436Met in exon 41 of MUC5B: This variant is not expected to have clinical si gnificance because it has been identified in 3.2% (269/8482) of European America n chromosomes from a broad population by the NHLBI Exome Sequencing Project (htt p://evs.gs.washington.edu/EVS; dbSNP rs55657020). -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.62
T
BayesDel_noAF
Benign
-0.63
CADD
Benign
17
DANN
Benign
0.65
DEOGEN2
Benign
0.021
T
Eigen
Benign
-0.53
Eigen_PC
Benign
-0.66
FATHMM_MKL
Benign
0.067
N
LIST_S2
Benign
0.57
T
MetaRNN
Benign
0.0031
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.9
M
PhyloP100
-0.0030
PrimateAI
Benign
0.42
T
PROVEAN
Benign
-1.5
N
REVEL
Benign
0.037
Sift
Benign
0.12
T
Vest4
0.10
ClinPred
0.0092
T
GERP RS
0.71
PromoterAI
-0.031
Neutral
Varity_R
0.042
gMVP
0.58
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs55657020; hg19: chr11-1278796; API